Life Technologies Corporation
LIFE and RainTree Oncology Services today announced they have
entered into a collaboration agreement designed to further the advancement of
personalized care for cancer patients.
Through the collaboration, RainTree and Life Technologies will seek to make
the latest advances in molecular testing available to the broader patient
market and will work to develop a streamlined protocol for entering patients
into clinical trials for new targeted therapies.
Key elements of the collaboration are:
o Collaborate on matching oncology patients to clinical trials using a Next
Generation Sequencing Oncology screening panel;
o Develop a clinical trials recruitment database which incorporates
RainTree's broad patient data set, enhanced by other data sources,
including Life's Compendia analytics engine;
o Educate private payors and health plans about the benefits of Next
Generation Sequencing; and
o Build and market comprehensive product, test and data offerings for
clinical research organizations.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in